Marijn de Bruin

Marijn de Bruin

Auto-generated profile, based on publicly available information

Marijn de Bruin

Radboud University Medical Center, Institute of Health Sciences, IQ Health, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands; Rijksinstituut voor Volksgezondheid en Milieu, Dpt. of Behaviour and Health, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, PO Box 1, 3720 BA, Bilthoven, the Netherlands

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2013 in Health Psychology Review
Verified
Journal Article
Open access
GPGjalt-Jorn Ygram Peters
Gjalt-Jorn Ygram Peters
MBMarijn de Bruin
Marijn de Bruin
RCRik Crutzen
Rik Crutzen
There is a need to consolidate the evidence base underlying our toolbox of methods of behaviour change. Recent efforts to this effect have conducted meta-regressions on evaluations of behaviour change interventions, deriving each method's effectiveness from its association to intervention effect size. However, there are a range of issues that raise concern about whether this approach is actually furthering or instead obstructing the advancement of health psychology theories and the quality of health behaviour change interventions. Using examples from theory, the literature and data from previous meta-analyses, these concerns and their implications are explained and illustrated. An iterative protocol for evidence base accumulation is proposed that integrates evidence derived from both experimental and applied behaviour change research, and combines theory development in experimental settings with theory testing in applied real-life settings. As evidence gathered in this manner accumulates, a cumulative science of behaviour change can develop.

23 January 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
GHGimena Hernandez
Gimena Hernandez
OGOlatz Garin
Olatz Garin
Alexandra L DimaAlexandra L Dima
Alexandra L Dima
APAngels Pont
Angels Pont
MMMarc Marti-Pastor
Marc Marti-Pastor
AGASTRO-LAB Group
ASTRO-LAB Group
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The EQ-5D, developed in 1990 by the EuroQoL group, is one of the most widely employed generic tools to measure Health-Related Quality of Life (HRQoL) and considered suitable for asthma patients. In 2009, the EuroQol Group developed a new EQ-5D version to overcome limitations related to its consistently reported high ceiling effect. To become more sensitive for assessing HRQoL in further patient populations, the number of responses was increased from 3 to 5 levels (EQ-5D-5L). Moreover, the availability of well-defined requirements for its online administration allows the use of EQ-5D-5L to monitor HRQoL in e-Health programs. To date, there are no studies evaluating metric properties of the new EQ-5D-5L in asthma patients. Objective: To examine the distribution, construct validity, and reliability of the new EQ-5D-5L questionnaire administered online to adults with asthma. Methods: Evaluation of asthma patients (18-40 years) from primary care setting in France and England, who self-completed the EQ-5D-5L questionnaire online. Inclusion criteria were: persistent asthmatic patients, with >6 months of prescribed drug of Inhaled Corticosteroids (ICs) and/or LABAs during the 12 months prior to inclusion. The EQ-5D index was obtained by applying the English preference value set for the new EQ-5D-5L and the French 3L-5L crosswalk value set. Both value sets produced single preference-based indices ranging from 1 (best health state) to negative values (health states valued as worse than death), where 0 is equal to death, allowing the calculation of Quality-Adjusted Life-Years (QALYs). Responses to dimensions and index distribution, including ceiling and floor effects, were examined. Construct validity was assessed by comparing means of known groups by analyses of variance and effect sizes (ES). Results: Evaluation of asthma patients (18-40 years) from primary care setting in France and England, who self-completed the EQ-5D-5L questionnaire online. Inclusion criteria were persistent asthma defined as >6 months of prescribed drug of Inhaled Corticosteroids (ICs) and/or Long-Acting Beta-Agonists (LABAs) during the 12 months prior to inclusion. The EQ-5D index was obtained by applying the English preference value set for the new EQ-5D-5L and the French 3L-5L crosswalk value set. Both value sets produced single preference-based indices ranging from 1 (best health state) to negative values (health states valued as worse than death), where 0 is equal to death, allowing the calculation of Quality-Adjusted Life-Years (QALYs). Responses to dimensions and index distribution, including ceiling and floor effects, were examined. Construct validity was assessed by comparing means of known groups by analyses of variance and calculation of effect sizes. Conclusions: The new EQ-5D-5L questionnaire has an acceptable ceiling effect, a good construct validity based on discriminant ability for distinguishing among health-related known groups, and a high reliability, supporting its adequacy for assessing HRQoL in asthma patients. The completion of the EQ-5D-5L by most of the online respondents supports the feasibility of this administration form.

1 June 2017 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
MBMarijn de Bruin
Marijn de Bruin
EOEdwin J M Oberjé
Edwin J M Oberjé
WVWolfgang Viechtbauer
Wolfgang Viechtbauer
HNHans-Erik Nobel
Hans-Erik Nobel
MHMickaël Hiligsmann
Mickaël Hiligsmann
JPJan M Prins
Jan M Prins

1 November 2018 in Health Technology Assessment
Verified
Journal Article
Closed access
AAAlison Avenell
Alison Avenell
CRClare Robertson
Clare Robertson
ZSZoë Skea
Zoë Skea
EJElisabet Jacobsen
Elisabet Jacobsen
DBDwayne Boyers
Dwayne Boyers
MBMarijn De Bruin
Marijn De Bruin
Background: Adults with severe obesity [body mass index (BMI) of ≥ 35 kg/m2] have an increased risk of comorbidities and psychological, social and economic consequences.Objectives: Systematically review bariatric surgery, weight-management programmes (WMPs) and orlistat pharmacotherapy for adults with severe obesity, and evaluate the feasibility, acceptability, clinical effectiveness and cost-effectiveness of treatment.Data sources: Electronic databases including MEDLINE, EMBASE, PsycINFO, the Cochrane Central Register of Controlled Trials and the NHS Economic Evaluation Database were searched (last searched in May 2017).Review methods: Four systematic reviews evaluated clinical effectiveness, cost-effectiveness and qualitative evidence for adults with a BMI of ≥ 35 kg/m2. Data from meta-analyses populated a microsimulation model predicting costs, outcomes and cost-effectiveness of Roux-en-Y gastric bypass (RYGB) surgery and the most effective lifestyle WMPs over a 30-year time horizon from a NHS perspective, compared with current UK population obesity trends. Interventions were cost-effective if the additional cost of achieving a quality-adjusted life-year is < £20,000–30,000.Results: A total of 131 randomised controlled trials (RCTs), 26 UK studies, 33 qualitative studies and 46 cost-effectiveness studies were included. From RCTs, RYGB produced the greatest long-term weight change [–20.23 kg, 95% confidence interval (CI) –23.75 to –16.71 kg, at 60 months]. WMPs with very low-calorie diets (VLCDs) produced the greatest weight loss at 12 months compared with no WMPs. Adding a VLCD to a WMP gave an additional mean weight change of –4.41 kg (95% CI –5.93 to –2.88 kg) at 12 months. The intensive Look AHEAD WMP produced mean long-term weight loss of 6% in people with type 2 diabetes mellitus (at a median of 9.6 years). The microsimulation model found that WMPs were generally cost-effective compared with population obesity trends. Long-term WMP weight regain was very uncertain, apart from Look AHEAD. The addition of a VLCD to a WMP was not cost-effective compared with a WMP alone. RYGB was cost-effective compared with no surgery and WMPs, but the model did not replicate long-term cost savings found in previous studies. Qualitative data suggested that participants could be attracted to take part in WMPs through endorsement by their health-care provider or through perceiving innovative activities, with WMPs being delivered to groups. Features improving long-term weight loss included having group support, additional behavioural support, a physical activity programme to attend, a prescribed calorie diet or a calorie deficit.Limitations: Reviewed studies often lacked generalisability to UK settings in terms of participants and resources for implementation, and usually lacked long-term follow-up (particularly for complications for surgery), leading to unrealistic weight regain assumptions. The views of potential and actual users of services were rarely reported to contribute to service design. This study may have failed to identify unpublished UK evaluations. Dual, blinded numerical data extraction was not undertaken.Conclusions: Roux-en-Y gastric bypass was costly to deliver, but it was the most cost-effective intervention. Adding a VLCD to a WMP was not cost-effective compared with a WMP alone. Most WMPs were cost-effective compared with current population obesity trends.Future work: Improved reporting of WMPs is needed to allow replication, translation and further research. Qualitative research is needed with adults who are potential users of, or who fail to engage with or drop out from, WMPs. RCTs and economic evaluations in UK settings (e.g. Tier 3, commercial programmes or primary care) should evaluate VLCDs with long-term follow-up (≥ 5 years). Decision models should incorporate relevant costs, disease states and evidence-based weight regain assumptions.Study registration: This study is registered as PROSPERO CRD42016040190.Funding: The National Institute for Health Research Health Technology Assessment programme. The Health Services Research Unit and Health Economics Research Unit are core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorate.

1 January 2021 in Health Services and Delivery Research
Verified
Journal Article
Open access
PDF file
SMSusan Michie
Susan Michie
MJMarie Johnston
Marie Johnston
ARAlexander J Rothman
Alexander J Rothman
MBMarijn de Bruin
Marijn de Bruin
MKMichael Kelly
Michael Kelly
SZSilje Zink
Silje Zink
Background: Many global health challenges may be targeted by changing people’s behaviour. Behaviours including cigarette smoking, physical inactivity and alcohol misuse, as well as certain dietary behaviours, contribute to deaths and disability by increasing the risk of cancers, cardiovascular diseases and diabetes. Interventions have been designed to change these health behaviours with a view to reducing these health risks. However, the effectiveness of these interventions has been quite variable and further information is needed to enhance their success. More information is needed about the specific processes that underlie the effectiveness of intervention strategies. Aim: Researchers have developed a taxonomy of 93 behaviour change techniques (i.e. the active components of an intervention that bring about behavioural change), but little is known regarding their potential mechanisms of action (i.e. the processes through which a behaviour change technique affects behaviour). We therefore aimed to examine links between behaviour change techniques and mechanisms of action. Method: First, we conducted a literature synthesis study of 277 behaviour change intervention studies, from which we extracted information on links, described by authors, between behaviour change techniques and mechanisms of action, and identified an average of 10 links per intervention report. Second, behaviour change experts (n = 105) were engaged in a three-round consensus study in which they discussed and rated their confidence in the presence/absence of ‘links’ and ‘non-links’ between commonly used behaviour change techniques (n = 61) and a set of mechanisms of action (n = 26). Ninety links and 460 ‘non-links’ reached the pre-set threshold of 80% agreement. To enhance the validity of these results, a third study was conducted that triangulated the findings of the first two studies. Discrepancies and uncertainties between the studies were included in a reconciliation consensus study with a new group of experts (n = 25). The final results identified 92 definite behaviour change technique–mechanism of action links and 465 definite non-links. In a fourth study, we examined whether or not groups of behaviour change techniques used together frequently across interventions revealed shared theoretical underpinnings. We found that experts agreed on the underlying theory for three groups of behaviour change techniques. Results: Our results are potentially useful to policy-makers and practitioners in selecting behaviour change techniques to include in behaviour change interventions. However, our data do not demonstrate that the behaviour change techniques are effective in targeting the mechanism of action; rather, the links identified may be the ‘best bets’ for interventions that are effective in changing mechanisms of action, and the non-links are unlikely to be effective. Researchers examining effectiveness of interventions in either primary studies or evidence syntheses may consider these links for further investigation. Conclusion: To make our results usable by researchers, practitioners and policy-makers, they are available in an online interactive tool, which enables discussion and collaboration (https://theoryandtechniquetool.humanbehaviourchange.org/); accessed 1 March 2020. This work, building on previous work to develop the behaviour change technique taxonomy, is part of an ongoing programme of work: the Human Behaviour Change Project (www.humanbehaviourchange.org/; accessed 1 March 2020). Funding: This project was funded by the Medical Research Council via its Methodology Panel: ‘Developing methodology for designing and evaluating theory-based complex interventions: an ontology for linking behaviour change techniques to theory’ (reference MR/L011115/1).

2 January 2017 in Psychology & Health
Verified
Journal Article
Closed access
KBKasia Banas
Kasia Banas
RLRamsey A. Lyimo
Ramsey A. Lyimo
HHHarm J. Hospers
Harm J. Hospers
AVAndre van der Ven
Andre van der Ven
MBMarijn de Bruin
Marijn de Bruin
Objectives: Combination antiretroviral therapy (cART) for HIV is widely available in sub-Saharan Africa. Adherence is crucial to successful treatment. This study aimed to apply an extended theory of planned behaviour (TPB) model to predict objectively measured adherence to cART in Tanzania. Design: Prospective observational study (n = 158) where patients completed questionnaires on demographics (Month 0), socio-cognitive variables including intentions (Month 1), and action planning and self-regulatory processes hypothesised to mediate the intention–behaviour relationship (Month 3), to predict adherence (Month 5). Main outcome measures: Taking adherence was measured objectively using the Medication Events Monitoring System (MEMS) caps. Model tests were conducted using regression and bootstrap mediation analyses. Results: Perceived behavioural control (PBC) was positively (β = .767, p < .001, R2 = 57.5%) associated with adherence intentions. Intentions only exercised an indirect effect on adherence (B = 1.29 [0.297–3.15]) through self-regulatory processes (B = 1.10 [0.131–2.87]). Self-regulatory processes (β = .234, p = .010, R2 = 14.7%) predicted better adherence. Conclusion: This observational study using an objective behavioural measure, identified PBC as the main driver of adherence intentions. The effect of intentions on adherence was only indirect through self-regulatory processes, which were the main predictor of objectively assessed adherence.